Dehaier Medical Announces the Results of 2015 Annual General Meeting

Dec 31, 2015, 06:00 ET from Dehaier Medical Systems Ltd.

BEIJING, Dec. 31, 2015 /PRNewswire/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier Medical" or the "Company"), which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced the results of its 2015 annual general meeting of shareholders. The meeting, which was originally scheduled for December 29, 2015, was adjourned to 9:00 p.m., Eastern Standard Time, on Wednesday, December 30, 2015 in order to meet quorum requirements.

During the meeting, the shareholders of Dehaier approved all of the following matters submitted to them:

(i)     Election of Xiaoguang Shen and Huili (Alisa) Li as Class II members of the Board of Directors, to serve a term expiring at the Annual Meeting of Shareholders in 2018 or until their successors are duly elected and qualified;

(ii)    Ratification of the appointment of Friedman LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2015;

(iii)  Transaction of any other business properly coming before the meeting.

About Dehaier Medical Systems Ltd.

Dehaier Medical is an emerging leader in the development, marketing and sale of medical products, including medical devices and wearable sleep respiratory products in China and international markets. The company develops and assembles its self-branded medical devices and sleep respiratory products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from HEYER (Germany) and Timesco (UK). Dehaier Medical's technology is based on six patents and eleven software copyrights. More information may be found at

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact:

Dehaier Medical Systems Limited Janice Wang +86 10-5166-0080 ext. 211

SOURCE Dehaier Medical Systems Ltd.